Defining Resilience to Smoking Related Lung Disease: A Modified Delphi Approach from SPIROMICS.

RATIONALE Diagnosis of chronic obstructive pulmonary disease (COPD) relies on abnormal spirometry. However, spirometry may underestimate the effects of smoking, missing smokers with respiratory disease that have minimal or no airflow obstruction. OBJECTIVES Develop a multi-dimensional definition of a lung-related "resilient smoker" that is useful in research studies; then identify a resilient smoker subgroup in the SPIROMICS cohort using this definition. METHODS We performed a three-round modified Delphi survey among a panel of COPD experts to identify and reach a consensus on clinical and radiographic domains to be included in a lung-related resilient smoker definition. Consensus on domains of resilience was defined as ≥80% of experts voting "agree" or "strongly agree" on a 5-point Likert scale. The Delphi-derived definition of resilience was applied to SPIROMICS to identify resilient smokers, whom we then characterized using known biomarkers of COPD. RESULTS Consensus was achieved on 6 of 12 diagnostic items which include: cough and sputum production, dyspnea, radiographic measures of emphysema and small airways disease, exacerbations, and decline in FEV1. Although 892 SPIROMICS participants were classified as smokers with preserved lung function by spirometry, only 149 participants (16.7%) qualified as resilient smokers by our definition. Blood biomarker expression of C-reactive protein (CRP) and soluble tumor necrosis receptor factor1A (sTNFRSF1A) was lower in resilient than non-resilient smokers (P=0.02 and P=0.03). CONCLUSIONS A Delphi-derived consensus definition of resilient smoker identified 83.3% of smokers with preserved spirometry as "non-resilient" based on the presence of adverse effects of smoking on the lung. Resilient smokers were biologically distinct from non-resilient smokers based on CRP measurements. Clinical trial registered with ClinicalTrials.gov (NCT01969344).

[1]  V. Kim,et al.  Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort , 2020, International journal of chronic obstructive pulmonary disease.

[2]  B. Yawn,et al.  The Burden of Cough and Phlegm in People With COPD: A COPD Patient-Powered Research Network Study. , 2020, Chronic obstructive pulmonary diseases.

[3]  I. Pavord,et al.  An Expert Consensus Framework for Asthma Remission as a Treatment Goal. , 2019, The Journal of allergy and clinical immunology.

[4]  J. Curtis,et al.  Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS , 2019, Chest.

[5]  P. Pasqualetti,et al.  Early management of COPD: where are we now and where do we go from here? A Delphi consensus project , 2019, International journal of chronic obstructive pulmonary disease.

[6]  Meilan K. Han,et al.  Defining Impaired Respiratory Health. A Paradigm Shift for Pulmonary Medicine , 2018, American journal of respiratory and critical care medicine.

[7]  Eyal Oren,et al.  The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States , 2018, JAMA.

[8]  H. Collard,et al.  Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis. An International Modified Delphi Survey , 2017, American journal of respiratory and critical care medicine.

[9]  E. Hoffman,et al.  Airway Mucin Concentration as a Marker of Chronic Bronchitis , 2017, The New England journal of medicine.

[10]  Meilan K. Han,et al.  Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort , 2017, The Lancet. Respiratory medicine.

[11]  Robert Paine,et al.  Respiratory Symptoms Items from the COPD Assessment Test Identify Ever‐Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort , 2017, Annals of the American Thoracic Society.

[12]  J. Wedzicha,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary , 2017, European Respiratory Journal.

[13]  J. Curtis,et al.  Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS , 2017, American journal of respiratory and critical care medicine.

[14]  Robert Paine,et al.  Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. , 2016, The New England journal of medicine.

[15]  T. Maher,et al.  Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique , 2015, Advances in Therapy.

[16]  Meilan K. Han,et al.  Clinical and Radiologic Disease in Smokers With Normal Spirometry. , 2015, JAMA internal medicine.

[17]  D. Kaminsky,et al.  How Common Is Airflow Limitation in Patients With Emphysema on CT Scan of the Chest? , 2015, Chest.

[18]  Eric A Hoffman,et al.  Variation in the percent of emphysema-like lung in a healthy, nonsmoking multiethnic sample. The MESA lung study. , 2014, Annals of the American Thoracic Society.

[19]  A. Buist,et al.  Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study , 2014, Thorax.

[20]  Lisa M LaVange,et al.  Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) , 2013, Thorax.

[21]  R. Luben,et al.  Original Contribution Longitudinal Association of C-Reactive Protein and Lung Function Over 13 Years The EPIC-Norfolk Study , 2013 .

[22]  Hassan Ghobadi,et al.  The Relationship between COPD Assessment Test (CAT) Scores and Severity of Airflow Obstruction in Stable COPD Patients , 2012, Tanaffos.

[23]  David R. Jacobs,et al.  Systemic Inflammation in Young Adults Is Associated with Abnormal Lung Function in Middle Age , 2010, PloS one.

[24]  E. Bleecker,et al.  Do symptoms predict COPD in smokers? , 2010, Chest.

[25]  P. Jones,et al.  Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.

[26]  R. Kronmal,et al.  Inflammatory markers and longitudinal lung function decline in the elderly. , 2008, American journal of epidemiology.

[27]  E. Wouters,et al.  Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD. , 2007, Respiratory medicine.

[28]  Chia-Chien Hsu,et al.  The Delphi Technique: Making Sense of Consensus , 2007 .

[29]  Kathy K. Franklin,et al.  Idea Generation and Exploration: Benefits and Limitations of the Policy Delphi Research Method , 2006 .

[30]  J. Vestbo,et al.  COPD: the dangerous underestimate of 15% , 2006, The Lancet.

[31]  K Larsson,et al.  Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. , 2003, Respiratory medicine.

[32]  E. Wouters,et al.  Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations , 2001, Thorax.

[33]  B. Burnand,et al.  The RAND/UCLA Appropriateness Method User's Manual , 2001 .

[34]  Hwan Yeom Chang,et al.  Original Research , 2000 .

[35]  H. Saito,et al.  The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[36]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[37]  D. Postma,et al.  Decline of FEV1 by age and smoking status: facts, figures, and fallacies. , 1997, Thorax.

[38]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[39]  G. Borsboom,et al.  Discrepancies between longitudinal and cross-sectional change in ventilatory function in 12 years of follow-up. , 1994, American journal of respiratory and critical care medicine.

[40]  R. Brook,et al.  Consensus methods: characteristics and guidelines for use. , 1984, American journal of public health.

[41]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[42]  Murray Turoff,et al.  The Delphi Method: Techniques and Applications , 1976 .